KZA 0.00% 8.0¢ kazia therapeutics limited

KZA Media Thread, page-1432

  1. 193 Posts.
    lightbulb Created with Sketch. 85
    Thanks Onesurfed. I saw this abstract which concludes that PI3K-Akt-mTOR and ERK/MEK kinase pathways constitute relevant targets in aggressive meningioma therapy.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795176/
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.